Reuters -- Swiss drugmaker Roche’s pharma and diagnostics units will significantly outpace the market this year, the group’s head was quoted as saying in an interview on Wednesday.
Reuters -- Swiss drugmaker Roche’s pharma and diagnostics units will significantly outpace the market this year, the group’s head was quoted as saying in an interview on Wednesday.
